E-LIB Suche - Ergebnisse für: Vickery, Stephen B.

1

A call to action: Studying the shortened duration of ceftri..:

Boyd, Tyler ; Bryant, Darius ; Vickery, Stephen B.
American Journal of Health-System Pharmacy. , 2024

Link: https://doi.org/10.1093/..

2

Differentiating probable nitrofurantoin-induced drug fever ..:

Vickery, Stephen B. ; Burch, Andrew D. ; Vickery, P. Brittany
Mental Health Clinician. 12 (2022) 3 - p. 205-209 , 2022

Link: https://doi.org/10.9740/..

3

Rifampin Augmentation in Hardware Infections: A Case Report..:

Mozol, Yuliya P. ; Vickery, Stephen B. ; Kaderli, Brian J..
Journal of Pharmacy Technology. 35 (2019) 5 - p. 230-231 , 2019

Link: https://doi.org/10.1177/..

4

Successful Use of Ceftolozane-Tazobactam to Treat a Pulmona..:

Vickery, Stephen B. ; McClain, David ; Wargo, Kurt A.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36 (2016) 10 - p. e154-e159 , 2016

Link: https://doi.org/10.1002/..

5

Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatm..:

Klibanov, Olga M. ; Vickery, Stephen B. ; Olin, Jacqueline L...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 32 (2012) 2 - p. 173-190 , 2012

Link: https://doi.org/10.1002/..

6

Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatm..:

Klibanov, Olga M. ; Williams, Shannon H. ; Smith, Lisa S...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 31 (2011) 10 - p. 951-974 , 2011

Link: https://doi.org/10.1592/..

7

Differentiating probable nitrofurantoin-induced drug fever ..:

Vickery, Stephen B ; Burch, Andrew D ; Vickery, P. Brittany
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190270/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Rifampin Augmentation in Hardware Infections: A Case Report..:

Mozol, Yuliya P ; Vickery, Stephen B ; Kaderli, Brian J.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706949/. , 2019

Link: http://www.ncbi.nlm.nih...

9

Differentiating probable nitrofurantoin-induced drug fever ..:

Stephen B. Vickery, PharmD, BCPS ; Andrew D. Burch, PharmD Candidate ; P. Brittany Vickery, PharmD, BCPS, BCPP, CPP
https://theijpt.org/doi/pdf/10.9740/mhc.2022.06.205. , 2022

Link: https://doi.org/10.9740/..

10

Clinical Presentation and Outcomes of Diabetic Ketoacidosis..:

Grasch, Jennifer L. ; Lammers, Sydney ; Scaglia Drusini, Florencia...
Obstetrics & Gynecology. , 2024

Link: https://doi.org/10.1097/..

11

Structural basis of lipopolysaccharide maturation by the O-..:

Ashraf, Khuram U. ; Nygaard, Rie ; Vickery, Owen N....
Nature. 604 (2022) 7905 - p. 371-376 , 2022

Link: https://doi.org/10.1038/..

12

Participant characteristics and safety outcomes of peanut o..:

Ciaccio, Christina ; Goldsobel, Alan B. ; Anagnostou, Aikaterini...
Annals of Allergy, Asthma & Immunology. 129 (2022) 6 - p. 758-768.e4 , 2022

Link: https://doi.org/10.1016/..

13

Continuous and Daily Oral Immunotherapy for Peanut Allergy:..:

Vickery, Brian P. ; Vereda, Andrea ; Nilsson, Caroline...
The Journal of Allergy and Clinical Immunology: In Practice. 9 (2021) 5 - p. 1879-1889.e13 , 2021

Link: https://doi.org/10.1016/..

14